First Approval for Osilodrostat for Cushing Syndrome, in EU First Approval for Osilodrostat for Cushing Syndrome, in EU

Move marks the first worldwide approval for cortisol synthesis inhibitor that normalizes cortisol levels in most patients with Cushing syndrome.International Approvals
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Alert Source Type: news